Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Taisho scientists isolate and and characterize new antifungal agent

March 5, 1999

Wyeth-Ayerst to market Abelcet in the U.K.

March 5, 1999

Novartis obtains first western approval for new antimalarial drug combination

March 4, 1999

Pfizer claims new, improved compositions of alatrofloxacin

March 4, 1999

New lantibiotic isolated and characterized by U. of Maryland group

March 4, 1999

Cubist Pharmaceuticals initiates pivotal clinical trials for daptomycin

March 3, 1999

Pfizer discloses novel macrolide antibiotics

March 3, 1999

Cubist reports new developments in antibiotic program

Feb. 26, 1999

Bayer claims oxazolidinones active against Gram-positive bacteria and mycobacteria

Feb. 26, 1999

New tradename announced for Magainin's pexiganan

Feb. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...